Measles Inclusion-Body Encephalitis after Allogeneic Stem-Cell Transplantation
Benjamin Némoz(Centre Hospitalier Universitaire de Grenoble), Olivier Épaulard(Centre National de la Recherche Scientifique), Cyrille Mathieu(Université Claude Bernard Lyon 1), Julien Lupo(Université Joseph Fourier), Anne Thiebaut(Laboratoire d'Economie Appliquée de Grenoble), Bryce Leterrier(Inserm), Anaïs Dartevel(Centre Hospitalier Universitaire de Grenoble), Denis Gerlier(Université Claude Bernard Lyon 1), Meriadeg Ar Gouilh(Centre Hospitalier Universitaire de Caen Normandie), Karin Pernet-Gallay(Grenoble Institute of Neurosciences), Sylvie Berthier(Centre Hospitalier Universitaire de Grenoble), Patrice Morand(Centre Hospitalier Universitaire de Grenoble), J Boutonnat(Centre Hospitalier Universitaire de Grenoble)
Cited by 0
Related Papers
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
|Clinical Microbiology and Infection|2021|107
Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus
|Antiviral Research|2013|71
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG
|Critical Care|2023|65
Levamisole-induced vasculopathy: A systematic review
|Seminars in Arthritis and Rheumatism|2018|61
Hepatitis E and neuralgic amyotrophy: Five cases and review of literature
|Journal of Clinical Virology|2015|42